Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.698 EUR | -0.70% | +0.47% | -36.17% |
Apr. 08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 25 | Advicenne: ODD designation in cystinuria | CF |
Sales 2024 * | 4.2M 4.51M | Sales 2025 * | 5.75M 6.17M | Capitalization | 21M 22.55M |
---|---|---|---|---|---|
Net income 2024 * | -7M -7.52M | Net income 2025 * | 22M 23.62M | EV / Sales 2024 * | 10.4 x |
Net Debt 2024 * | 22.7M 24.37M | Net cash position 2025 * | 3.2M 3.44M | EV / Sales 2025 * | 3.1 x |
P/E ratio 2024 * |
-2.67
x | P/E ratio 2025 * |
0.83
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.22% |
1 day | -0.70% | ||
1 week | +0.47% | ||
Current month | -18.37% | ||
1 month | -16.97% | ||
3 months | -11.01% | ||
6 months | -2.41% | ||
Current year | -36.17% |
Managers | Title | Age | Since |
---|---|---|---|
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Chief Tech/Sci/R&D Officer | - | 23-03-31 | |
André Ulmann
BRD | Director/Board Member | - | 17-06-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | 11-04-28 | |
Catherine Dunand
BRD | Director/Board Member | 62 | 17-03-08 |
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.698 | -0.70% | 1 639 |
24-04-25 | 1.71 | +0.59% | 25,060 |
24-04-24 | 1.7 | -0.58% | 20,471 |
24-04-23 | 1.71 | +0.23% | 33,442 |
24-04-22 | 1.706 | +0.95% | 18,055 |
Real-time Euronext Paris, April 26, 2024 at 04:22 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.17% | 22.5M | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+55.39% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+4.72% | 8.75B |
- Stock Market
- Equities
- ALDVI Stock